🚧 構築中 — データが不正確な場合があります。企業や指標を随時追加しています。
DexCom, Inc. logo

DexCom, Inc.

DXCM•順位 #303•ヘルスケア•医療機器

時価総額

$29.4B

世界順位

#303

過去最高値

$51.8B

2021-12-31

総成長率

+0%

2026年以降

Market Cap Context

  • Larger than 17% of the 367 companies we track (globally).
  • Equivalent to 0.1% of United States's GDP (2025 data).
  • Just above: #302 adidas AG ($29.8B)
  • Just below: #304 The Kraft Heinz Company ($29.4B)
  • Best year: 2009 (+192%). Worst year: 2008 (-69%).

DexCom, Inc. Financial Breakdown (FY 2025)

Source: Yahoo Finance — DXCM annual filings (2025) →

$4.7B revenue · $0.9B operating income · $0.8B net income

  • ●Operating margin: 19.6% on $4.7B in revenue.
  • ●R&D is 12.9% of revenue ($0.6B).
  • ●Net income margin: 17.9% — $0.8B in profit.
  • ●Free cash flow: $1.1B (23.1% of revenue).

Cost / Operating Expenses

Total operating expenses $3.8B

Total

$3.8B

Cost of revenue· Product / service delivery costs (COGS)$1.9B49.6%
Research & development$0.6B16.0%
Selling, general & administrative· Sales, marketing, and corporate overhead$1.3B34.4%

Capital Expenditures

$0.4B

This fiscal year (near-total AI infrastructure buildout)

Free Cash Flow

$1.1B

Trailing twelve months

Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.

DexCom, Inc.について

DexCom, Inc. (DXCM) is a United States-based company in the Medical Devices industry, part of the Healthcare sector. With a current market capitalization of $29.4B, it is ranked #303 among the world's largest companies. Its market cap peaked at $51.8B and reached as high as rank #199 in 2021.

DexCom, Inc.の時価総額推移 (2026–2026)

DexCom, Inc. vs Sector Peers by Market Cap

Veeva Systems Inc.VEEV
$52.3B
Humana Inc.HUM
$50.7B
IDEXX Laboratories, Inc.IDXX
$44.1B
Biogen Inc.BIIB
$37.0B
Zoetis Inc.ZTS
$33.5B
DexCom, Inc.DXCM
$29.4B
Koninklijke Philips N.V.PHIA.AS
$25.4B
Merck KGaAMRK.DE
$20.0B

DexCom, Inc.を比較

順位の推移

年時価総額順位前年比
2026$29.4B#303(↑16)+14.8%
2025$25.6B#319(↓21)-14.7%
2024$30.0B#298(↓70)-37.3%
2023$47.9B#228(↓26)+9.6%
2022$43.7B#202(↓3)-15.6%
2021$51.8B#199(↑31)+45.2%
2020$35.7B#230(↑40)+69.0%
2019$21.1B#270(↑21)+82.6%
2018$11.6B#291(↑15)+108.7%
2017$5.5B#306(↓11)-3.9%
2016$5.8B#295(↓24)-27.1%
2015$7.9B#271(↑11)+48.8%
2014$5.3B#282(↑7)+55.5%
2013$3.4B#289(↑2)+160.6%
2012$1.3B#291(↓2)+46.0%
2011$898.1M#289(↓6)-31.8%
2010$1.3B#283(↓3)+69.1%
2009$778.5M#280(↑2)+192.4%
2008$266.3M#282(↓8)-68.7%
2007$851.8M#274(↓8)-10.4%
2006$951.2M#266(↓8)-33.9%
2005$1.4B#258

その他のヘルスケア企業

よくある質問

What is DexCom, Inc.'s market cap?

DexCom, Inc. (DXCM) has a market capitalization of $29.4B, making it the #303 largest company in the world by market cap.

What was DexCom, Inc.'s highest market cap?

DexCom, Inc.'s all-time high market cap was $51.8B, reached in 2021-12-31. Its highest rank was #199 in 2021.

What sector is DexCom, Inc. in?

DexCom, Inc. is in the Healthcare sector, specifically the Medical Devices industry. It is based in United States.

How has DexCom, Inc.'s market cap changed over time?

DexCom, Inc. has been tracked since 2026. Its market cap has grown by 0% from $29.4B in 2026 to $29.4B today.